Search
+
    SEARCHED FOR:

    MSN

    The life, death and rebirth of an AI-generated news outlet

    Irish broadcaster Dave Fanning's defamation lawsuit involves Kasturi Chakraborty and Hemin Bakir, former journalists at BNN Breaking, revealing the impact of AI-generated news on their reputations.

    Can humans live for 1,000 years or be immortal? 'Longevity Escape Velocity' explains this process. Here are details

    Some biologists and medical experts believe that cells in the human body can be rejuvenated in a way that their life expectancy can be more than the time spent. This is the theory of longevity escape velocity. By achieving this state, humans can live forever, they can become immortal.

    HCL lays off 350 employees working on Microsoft project: report

    According to reports, the workers, who were employed by HCL's client Microsoft's news outlet MSN, reportedly learned that they have been let go at a town hall meeting last week.

    MSN to launch generic anti-COVID pill Molnupiravir under 'Molulow' brand

    The group is all set to launch the generic Molnupiravir 200 mg capsules and it is being manufactured at its USFDA and MHRA accredited facility based out of Hyderabad, MSN Group said in a statement. Molulow will come as a pack of 4x10 capsule strips with each capsule in 200 mg strength.

    Panel to meet today to take up applications seeking nod for Molnupiravir

    The firms whose applications that will be taken up are Dr Reddy's Laboratories which has filed for approval in a consortium with five other companies and MSD, Hetero Labs, Natco Pharma, Aurobindo Pharma, Optimus Pharma, Strides Pharma, MSN Pharma and BDR Pharmaceuticals.

    Boehringer Ingelheim gets interim injunction against Dr. Reddy’s Labs, MSN Labs against copies of anti-diabetes drug

    In a statement to ET, BI confirmed it has obtained separate orders granting ad-interim injunction that restrains the two domestic pharmaceutical manufacturers from launching, making, using, offering for sale, selling, importing and/or exporting their respective generic version of empagliflozin drugs.

    The Economic Times
    BACK TO TOP